Bristol-Myers Squibb Company (BMY)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 49.14 |
| Open | 49.16 |
| Bid | 49.03 x 900 |
| Ask | 49.32 x 800 |
| Day's range | 48.96 - 49.47 |
| 52-week range | 47.58 - 69.74 |
| Volume | |
| Avg. volume | 15,482,259 |
| Market cap | 99.291B |
| Beta (5Y monthly) | 0.39 |
| PE ratio (TTM) | 12.69 |
| EPS (TTM) | 3.86 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | 2.40 (4.90%) |
| Ex-dividend date | 04 Apr 2024 |
| 1y target est | 52.41 |
ZacksNeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
NeoGenomics (NEO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksBristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know
Investors are likely to focus on Opdivo's demand, along with an incremental contribution from newer drugs, when Bristol-Myers (BMY) posts Q1 results.
ZacksCurious about Bristol Myers (BMY) Q1 Performance? Explore Wall Street Estimates for Key Metrics
Evaluate the expected performance of Bristol Myers (BMY) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
© 2024 Yahoo. All rights reserved.